DNA from <i>Lactobacillus paragasseri</i> SBT2055 Activates Plasmacytoid Dendritic Cells and Induces IFN-α via TLR9

DNA from <i>Lactobacillus paragasseri</i> SBT2055 Activates Plasmacytoid Dendritic Cells and Induces IFN-α via TLR9

Previously, we reported that <i>Lactobacillus paragasseri</i> SBT2055 (LG2055) activates plasmacytoid dendritic cells (pDCs) and induces interferon alpha (IFN-α) in vitro. Our clinical trial suggested that LG2055 intake may enhance pDC activity, supporting immune maintenance and reducing...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eiji Kobatake, Toshinobu Arai
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Microorganisms
Subjects:	plasmacytoid dendritic cells type I interferon interferon-α lactic acid bacteria <i>Lactobacillus paragasseri</i> SBT2055 Toll-like receptor 9
Online Access:	https://www.mdpi.com/2076-2607/13/7/1440
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The host cell factor DDX3 mediates sex dimorphism in the IFNα response of plasmacytoid dendritic cells upon TLR activation
by: Sebastian Schloer, et al.
Published: (2025-06-01)

Skim Milk Culture of <i>Lactobacillus johnsonii</i> SBT0309 Increases Intestinal Alkaline Phosphatase Activity and Inhibits Lipopolysaccharide-Induced Interleukin-8 Production in Intestinal Epithelial Cells
by: Michio Kawano, et al.
Published: (2025-02-01)

TLR7 rs179008 (A/T) and TLR7 rs3853839 (C/G) polymorphisms are associated with variations in IFN-α levels in HTLV-1 infection
by: Emmanuelle Giuliana Mendes Santana, et al.
Published: (2024-11-01)

The contribution of type-I IFN-mediated neuroinflammation to Parkinson's disease progression
by: Shuyan Chen, et al.
Published: (2025-07-01)

Plasma CXCL4–DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment
by: Anna Mennella, et al.
Published: (2024-08-01)

Deletion of gE in Herpes Simplex Virus 1 Leads to Increased Extracellular Virus Production and Augmented Interferon Alpha Production by Peripheral Blood Mononuclear Cells
by: Manon Claeys, et al.
Published: (2024-12-01)

Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling
by: Kassidy M. Jungles, et al.
Published: (2025-08-01)

Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain
by: Ti-Chuan Chiu, et al.
Published: (2025-06-01)

Lactobacillus paragasseri HM018, Isolated from Human Milk, Improves Intestinal Metabolism in Germ-Free Mice Humanized with Gut Microbiota from Pregnant Women during Pregnancy
by: TIAN Xiaoyan, ZHAO Junying, LIU Yanpin, LIU Bin, ZHANG Zhenzhen, ZHAO Yujin, ZHAO Yanyan, YUAN Yuying, LIU Lu, WANG Yaru, QIAO Weicang, CHEN Lijun
Published: (2025-07-01)

IMMUNOINFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TYPE I INTERFERON: NEW EVIDENCE
by: E. L. Nasonov, et al.
Published: (2019-09-01)

IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
by: Sophia Davidson, et al.
Published: (2016-08-01)

<i>Pseudorabies Virus</i> IE180 Inhibits Virus Replication by Activating the Type I Interferon Pathway
by: Feiyang Zheng, et al.
Published: (2025-06-01)

Research on NS1 Proteins of Group 2 Tembusu Virus Inhibiting the Production of Duck Type Ⅰ IFN
by: Yunzhen HUANG, et al.
Published: (2024-07-01)

IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response
by: Yujie Ding, et al.
Published: (2025-08-01)

Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities
by: James Tumlin, et al.
Published: (2025-01-01)

Evaluation of Diagnostic Performance of Three Commercial Interferon-Gamma Release Assays for <i>Mycobacterium tuberculosis</i>
by: Richard Kutame, et al.
Published: (2024-09-01)

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders
by: Anaïs Nombel, PharmD, et al.
Published: (2025-05-01)

Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
by: Li‐Min Wang, et al.
Published: (2023-01-01)

The dual role of type I interferons in bacterial infections: from immune defense to pathogenesis
by: Mingjie Qiu, et al.
Published: (2025-07-01)

Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin
by: Refaat Sadeq, et al.
Published: (2013-11-01)

Nailfold videocapillaroscopy findings are associated with IIM subtypes and IFN activation
by: Mingwei Tang, et al.
Published: (2025-03-01)

Upregulation of RIG‐I is Critical for Responsiveness to IFN‐α Plus Anti‐PD‐1 in Colorectal Cancer
by: Haihang Nie, et al.
Published: (2025-03-01)

Sequential activation of conventional and plasmacytoid dendritic cells in autoimmune pancreatitis and systemic lupus erythematosus: similarities and dissimilarities
by: Akane Hara, et al.
Published: (2025-02-01)

Age-dependent differences in type I interferon, IL-12 and pro-inflammatory cytokine production by porcine peripheral blood mononuclear cells in response to pseudorabies virus-infected cells
by: Manon S. C. Claeys, et al.
Published: (2025-07-01)

Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma
by: Laura Vízkeleti, et al.
Published: (2024-11-01)

Diffuse traumatic brain injury induced stimulator of interferons (STING) signaling in microglia drives cortical neuroinflammation, neuronal dysfunction, and impaired cognition
by: Jonathan M. Packer, et al.
Published: (2025-04-01)

Plasmacytoid urothelial carcinoma with duodenal metastasis—A rare tumor with unusual site of metastasis with grim outcome
by: Aparna Chenniappan, et al.
Published: (2023-01-01)

Resolution of the Expert Council «The role of type I interferon inhibitor in the treatment of patients with systemic lupus erythematosus»
by: A. M. Lila, et al.
Published: (2021-08-01)

Similarly to <i>BmToll9-1</i>, <i>BmToll9-2</i> Is a Positive Regulator of the Humoral Immune Response in the Silkworm, <i>Bombyx mori</i>
by: Jisheng Liu, et al.
Published: (2024-12-01)

Dermatoscopic features of blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature
by: Daniel Argüello-Ruiz, et al.
Published: (2024-10-01)

The role of type I interferon signaling in myeloid anti-tumor immunity
by: Sofie Patrizia Meyer, et al.
Published: (2025-03-01)

COPB1-knockdown induced type I interferon signaling activation inhibits Chlamydia psittaci intracellular proliferation
by: Nana Li, et al.
Published: (2025-03-01)

Digitoflavone Ameliorates Acute Lung Injury via Disturbing the Formation of Functional Stimulator of Interferon Genes Signalosome
by: Jun-Jie Li, et al.
Published: (2025-04-01)

An Introduction to Animal Behaviour /
by: Manning, Aubrey
Published: (1998)

Clinical significance of interferon status in patients with systemic lupus erythematosus. Preliminary data
by: T. A. Panafidina, et al.
Published: (2025-03-01)

Phase transition of WTAP regulates m6A modification of interferon-stimulated genes
by: Sihui Cai, et al.
Published: (2025-05-01)

A Comparison of Tests for Detecting Prior Exposure to <i>Coxiella burnetii</i> for Use with Q-VAX in Australian Human Q Fever Vaccination
by: Stephen Graves, et al.
Published: (2025-06-01)

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis
by: Aleksandra Antonczyk, et al.
Published: (2025-01-01)

Achieving superior ductility and toughening in as-cast 2055 Al–Li alloy through single-pass rolling with a small reduction ratio for homogenization
by: Sha Li, et al.
Published: (2025-07-01)

TLR3 rs3775291 C/T polymorphism is associated with elevated IFN-α level in asymptomatic HTLV-1 infection
by: Fabiane dos Santos Ferreira, et al.
Published: (2025-08-01)